913 related articles for article (PubMed ID: 18663165)
41. Effects of colesevelam on glucose absorption and hepatic/peripheral insulin sensitivity in patients with type 2 diabetes mellitus.
Henry RR; Aroda VR; Mudaliar S; Garvey WT; Chou HS; Jones MR
Diabetes Obes Metab; 2012 Jan; 14(1):40-6. PubMed ID: 21831167
[TBL] [Abstract][Full Text] [Related]
42. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
[TBL] [Abstract][Full Text] [Related]
43. Safety and efficacy of colesevelam HCl in the treatment of elderly patients.
Gavin JR; Jones MR; Ford DM; Truitt KE
Drugs Aging; 2014 Jun; 31(6):461-70. PubMed ID: 24777691
[TBL] [Abstract][Full Text] [Related]
44. The combination of colesevelam with sitagliptin enhances glycemic control in diabetic ZDF rat model.
Shang Q; Liu MK; Saumoy M; Holst JJ; Salen G; Xu G
Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(8):G815-23. PubMed ID: 22281473
[TBL] [Abstract][Full Text] [Related]
45. The glucose and lipid effects of colesevelam as monotherapy in drug-naïve type 2 diabetes.
Rosenstock J; Rigby SP; Ford DM; Tao B; Chou HS
Horm Metab Res; 2014 May; 46(5):348-53. PubMed ID: 24356792
[TBL] [Abstract][Full Text] [Related]
46. Colesevelam HCl effects on atherogenic lipoprotein subclasses in subjects with type 2 diabetes.
Rosenson RS; Abby SL; Jones MR
Atherosclerosis; 2009 Jun; 204(2):342-4. PubMed ID: 18996525
[TBL] [Abstract][Full Text] [Related]
47. Effect of colesevelam hydrochloride on glycemia and insulin sensitivity in men with the metabolic syndrome.
Vega GL; Dunn FL; Grundy SM
Am J Cardiol; 2011 Oct; 108(8):1129-35. PubMed ID: 21813109
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of the efficacy, safety and tolerability of miglitol in adult Indian patients with uncomplicated type 2 diabetes mellitus.
Singh KP; Periyandavar I; Rajadhyaksha GC; Jayaram S; Mishra AB; Kinagi S; Sharma A; Baliga VP
J Indian Med Assoc; 2007 Jun; 105(6):344, 346, 350. PubMed ID: 18232183
[TBL] [Abstract][Full Text] [Related]
49. The efficacy of colesevelam HCl in the treatment of heterozygous familial hypercholesterolemia in pediatric and adult patients.
Davidson M
Clin Ther; 2013 Aug; 35(8):1247-52. PubMed ID: 23916045
[TBL] [Abstract][Full Text] [Related]
50. Effects of colesevelam, rosiglitazone, or sitagliptin on glycemic control and lipid profile in patients with type 2 diabetes mellitus inadequately controlled by metformin monotherapy.
Rigby SP; Handelsman Y; Lai YL; Abby SL; Tao B; Jones MR
Endocr Pract; 2010; 16(1):53-63. PubMed ID: 19789153
[TBL] [Abstract][Full Text] [Related]
51. Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: Chinese PRESENT study.
Gao Y; Guo XH; Vaz JA;
Diabetes Obes Metab; 2009 Jan; 11(1):33-40. PubMed ID: 18494806
[TBL] [Abstract][Full Text] [Related]
52. Two-year effect of rosiglitazone in chinese poorly controlled type 2 diabetic patients.
Lee JK; Chu CH; Chuang MJ; Lin SC; Wang MC; Lu CC; Sun CC; Lam HC
Chang Gung Med J; 2006; 29(5):486-92. PubMed ID: 17214393
[TBL] [Abstract][Full Text] [Related]
53. Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia.
Knapp HH; Schrott H; Ma P; Knopp R; Chin B; Gaziano JM; Donovan JM; Burke SK; Davidson MH
Am J Med; 2001 Apr; 110(5):352-60. PubMed ID: 11286949
[TBL] [Abstract][Full Text] [Related]
54. Effect of acarbose in treatment of type II diabetes mellitus: a double-blind, crossover, placebo-controlled trial.
Soonthornpun S; Rattarasarn C; Thamprasit A; Leetanaporn K
J Med Assoc Thai; 1998 Mar; 81(3):195-200. PubMed ID: 9623011
[TBL] [Abstract][Full Text] [Related]
55. The role of colesevelam HCl in type 2 diabetes mellitus therapy.
Handelsman Y
Postgrad Med; 2009 May; 121(3 Suppl 1):19-24. PubMed ID: 19494474
[TBL] [Abstract][Full Text] [Related]
56. Colesevelam hydrochloride: usefulness of a specifically engineered bile acid sequestrant for lowering LDL-cholesterol.
Corsini A; Windler E; Farnier M
Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):1-9. PubMed ID: 19237992
[TBL] [Abstract][Full Text] [Related]
57. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study.
Wenying Y; Benroubi M; Borzi V; Gumprecht J; Kawamori R; Shaban J; Shah S; Shestakova M; Ligthelm R; Valensi P;
Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116
[TBL] [Abstract][Full Text] [Related]
58. Canagliflozin improves glycaemic control over 28 days in subjects with type 2 diabetes not optimally controlled on insulin.
Devineni D; Morrow L; Hompesch M; Skee D; Vandebosch A; Murphy J; Ways K; Schwartz S
Diabetes Obes Metab; 2012 Jun; 14(6):539-45. PubMed ID: 22226086
[TBL] [Abstract][Full Text] [Related]
59. Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study.
Khutsoane D; Sharma SK; Almustafa M; Jang HC; Azar ST; Danciulescu R; Shestakova M; Ayad NM; Guler S; Bech OM;
Diabetes Obes Metab; 2008 Mar; 10(3):212-22. PubMed ID: 18269636
[TBL] [Abstract][Full Text] [Related]
60. Effect of colesevelam HCl monotherapy on lipid particles in type 2 diabetes mellitus.
Rosenson RS; Rigby SP; Jones MR; Chou HS
Cardiovasc Drugs Ther; 2014 Jun; 28(3):229-36. PubMed ID: 24710760
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
